Thera-T Pharmaceutics (Salt Lake City, UT), develops a two-component, AI-guided T cell therapy, targeting multiple cancer markers while reducing toxicity—earning the University of Utah’s 2025 Breakthrough Technology of the Year award.

Vector (Draper, UT), led by former Army aviator Andy Yakulis, secures a multi-million SOCOM contract, providing attritable drones via a subscription “Modern Warfare as a Service” model, with fiber-optic FPV integration, tactical training, and battlefield innovation showcased at the 47G Summit.

Matia Mobility, co-founded by Steven Boal, delivers a groundbreaking standing device for paraplegics, restoring independence and dignity. FDA- and VA-approved, made in Utah, it transforms lives while navigating insurance and accessibility challenges.

Salt Lake City biotech firm Seek Labs expands its AI-driven Global Disease Atlas to map hemorrhagic fever and orthopoxvirus families, advancing programmable CRISPR therapeutics for faster global outbreak response and prevention.

Appli celebrates its first year with 10 credit union partners, $1 billion in lending calculations, and AI-powered calculators achieving 15–20% conversion rates, empowering community banks to better understand member borrowing behavior.

Clarity Pharmaceuticals has signed a three-year copper-67 supply agreement with Utah-based Nusano, further validating Nusano’s $300 million West Valley facility as a key player in domestic isotope production for cancer therapies.

Tendo’s MDsave Marketplace has been named to TIME’s Top HealthTech 2025 list for transforming healthcare access with transparent pricing, broad provider networks, and scalable solutions for patients, care navigators and employers.

Nusano (West Valley City, UT) signs multi-isotope supply agreement with Ariceum Therapeutics (Berlin) securing critical isotopes for radiopharmaceutical development. It highlights supply-chain bottlenecks and the strategic role of infrastructure in emerging cancer therapies.